Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
- Conditions
- esophageal neoplasm
- Registration Number
- JPRN-UMIN000000710
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 81
Not provided
1) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2) Patients requiring the administration of phenytoin or warfarin potassium 3) Pregnant or lactating women or women of childbearing potential 4) Psychosis 5) Patients requiring systemic steroids medication 6) HBs antigen positive 7) Uncontrollable diabetes millutus or requiring administration of insulin 8) Uncontrollable hypertension 9) History of myocardial infarction or unstable angina pectoris 10) Interstitial pneumonia, fibroid lung or severe emphysema 11) Active bacterial or fungous infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method